These 2 Stocks Hit Fresh 52-Week Highs – One Earns A Massive 166% Price Target Hike From JPMorgan
Barclays raised Blue Bird’s price target to $85, adding that the group remains investable, while JPMorgan raised its price target on Anterix to $133 from $50 while maintaining an ‘Overweight’ rating.
Stocktwits
More News
Anterix (ATEX) Up 31.2% Since Last Earnings Report: Can It Continue?
Anterix (ATEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Strength Seen in Anterix (ATEX): Can Its 4.8% Jump Turn into More Strength?
Anterix (ATEX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
Can the Launch of Bandwidth Build Platform Propel BAND Stock Higher?
Build pushes Bandwidth deeper into agentic AI, automating communications setup as enterprise cloud adoption and AI-powered apps fuel growth.
Zacks
Anterix Insider Transaction: 4,291 Shares Sold as Utility Broadband Stock Gains 170% This Past Year
Key PointsATEX's CFO sold 4,291 shares of Common Stock for a transaction value of ~$341,000 on June 17, 2026...
Nasdaq News: Markets
Can Viavi's New Validation Solution Shape the Future of AI Networking?
VIAV's first UET validation platform targets AI network deployment, helping cloud and neocloud players reduce testing costs and improve scale.
Zacks
Anterix Surges 163% in the Past Year: Should You Bet on the Stock?
ATEX's 163% surge, utility broadband push and 900 MHz spectrum edge spotlight its growth runway, but long utility sales cycles remain a risk.
Zacks
Bandwidth Surges 258% in the Past Year: Should You Buy the Stock?
BAND's 258% surge reflects momentum from cloud communications, AI adoption, enterprise growth and global expansion, making it a high-flying stock.